Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02195479||Active, not recruiting
|A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma||
||706||All||18 Years and older (Adult, Older Adult)||NCT02195479||CR104761
|December 9, 2014||November 21, 2017||October 20, 2021||July 21, 2014||May 13, 2019||December 17, 2018||